Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational Phase II-III trial results. - Duvic,M.; Hymes,K.; Heald,P.; Breneman,D.; Martin,A.G.; Myskowski,P.; Crowley,C.; Yocum,R.C. (J Clin Oncol, 2001)